Literature DB >> 19236300

Pathological gambling and hypersexuality in cabergoline-treated prolactinoma.

Henrik Falhammar, Jennifer Y Yarker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19236300     DOI： 10.5694/j.1326-5377.2009.tb02289.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  13 in total

1.  Cabergoline associated with first episode mania.

Authors:  Yael T Harris; Alexander Z Harris; Jose M Deasis; Stephen J Ferrando; Nirmala Reddy; Robert C Young
Journal:  Psychosomatics       Date:  2012-05-31       Impact factor: 2.386

Review 2.  Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.

Authors:  Anahid Hamidianjahromi; Nicholas A Tritos
Journal:  Rev Endocr Metab Disord       Date:  2022-09-20       Impact factor: 9.306

3.  Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.

Authors:  Sunita M C De Sousa; Ian M Chapman; Henrik Falhammar; David J Torpy
Journal:  Endocrine       Date:  2016-09-06       Impact factor: 3.633

Review 4.  Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature.

Authors:  Paolo Solla; Marco Bortolato; Antonino Cannas; Cesare Salvatore Mulas; Francesco Marrosu
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

Review 5.  Treating prolactinomas with dopamine agonists: always worth the gamble?

Authors:  Sean Noronha; Victoria Stokes; Niki Karavitaki; Ashley Grossman
Journal:  Endocrine       Date:  2015-09-04       Impact factor: 3.633

6.  Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study.

Authors:  Maya Barake; A Eden Evins; Luke Stoeckel; Gladys N Pachas; Lisa B Nachtigall; Karen K Miller; Beverly M K Biller; Nicholas A Tritos; Anne Klibanski
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

7.  Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease.

Authors:  Bruno B Averbeck; Atbin Djamshidian; Sean S O'Sullivan; Charlotte R Housden; Jonathan P Roiser; Andrew J Lees
Journal:  Behav Neurosci       Date:  2013-04       Impact factor: 1.912

Review 8.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

9.  Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study.

Authors:  Irina Bancos; Michael R Nannenga; J Michael Bostwick; Michael H Silber; Dana Erickson; Todd B Nippoldt
Journal:  Clin Endocrinol (Oxf)       Date:  2013-12-16       Impact factor: 3.478

10.  Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study.

Authors:  M Zibetti; S Grottoli; G Beccuti; F Guaraldi; G Natta; V Cambria; N Prencipe; A Cicolin; E Montanaro; L Lopiano; E Ghigo
Journal:  J Endocrinol Invest       Date:  2020-12-12       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.